Stay updated on Ruxolitinib vs BAT in Chronic GvHD Clinical Trial

Sign up to get notified when there's something new on the Ruxolitinib vs BAT in Chronic GvHD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ruxolitinib vs BAT in Chronic GvHD Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    No significant changes detected to core study information; the page content remains focused on the study design, eligibility criteria, interventions, and outcomes.
    Difference
    0.1%
    Check dated 2025-10-30T11:22:26.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    The page now shows a new revision tag (v3.2.0) replacing the old one (v3.0.2), indicating a release upgrade with no other substantive content changes.
    Difference
    0.0%
    Check dated 2025-10-01T04:47:22.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Updates the revision tag from v3.0.2 to v3.1.0, indicating a new release version without substantive changes to visible content.
    Difference
    0.0%
    Check dated 2025-09-30T03:20:14.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Shift in page focus from Parkinson-associated proteins to oncogene/proto-oncogene protein families, altering core content and protein naming references.
    Difference
    0.4%
    Check dated 2025-09-22T23:43:15.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Minor patch: version bumped from v3.0.1 to v3.0.2 and the 'Back to Top' link removed; no substantive changes to core content, pricing, stock, or time-slot information.
    Difference
    0.1%
    Check dated 2025-09-15T19:30:03.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The page has been updated to reflect the final analysis of the Phase III REACH3 Study on Ruxolitinib, with a new publication date and revision number.
    Difference
    0.3%
    Check dated 2025-09-08T15:05:37.000Z thumbnail image

Stay in the know with updates to Ruxolitinib vs BAT in Chronic GvHD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ruxolitinib vs BAT in Chronic GvHD Clinical Trial page.